T1	Participants 56 129	in subjects with a history of insulin resistance and colorectal adenomas.
T2	Participants 538 661	subjects with four possible combinations of risk factors, including insulin resistance and a history of adenomatous polyps.
T3	Participants 741 753	total of 23;
T4	Participants 1312 1417	subjects with insulin resistance, a history of polyps, or exposure to a chemoprotective legume-rich diet.
